Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -28,079 | -12,201 | -6,883 | N/A |
| Depreciation Amortization | 252 | 67 | 4 | N/A |
| Accounts payable and accrued liabilities | -72 | 527 | -1,661 | N/A |
| Other Working Capital | 1,256 | 1,698 | -2,281 | N/A |
| Other Operating Activity | 4,890 | 195 | 2,776 | 0 |
| Operating Cash Flow | $-21,753 | $-9,715 | $-8,045 | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,305 | -885 | -137 | N/A |
| Investing Cash Flow | $-1,305 | $-885 | $-137 | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 3,000 | 3,000 | 100 | N/A |
| Debt Repayment | -534 | N/A | -22 | N/A |
| Common Stock Issued | 86,060 | N/A | N/A | N/A |
| Other Financing Activity | 50,992 | 13,471 | 15,821 | 0 |
| Financing Cash Flow | $139,518 | $16,471 | $15,899 | $N/A |
| Beginning Cash Position | 13,729 | 7,858 | 141 | N/A |
| End Cash Position | 130,189 | 13,729 | 7,858 | N/A |
| Net Cash Flow | $116,460 | $5,871 | $7,717 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -21,753 | -9,715 | -8,045 | N/A |
| Capital Expenditure | -1,305 | -885 | -137 | N/A |
| Free Cash Flow | -23,058 | -10,600 | -8,182 | 0 |